Acquired perforating dermatosis associated with natalizumab

J Am Acad Dermatol. 2013 Jun;68(6):e185-7. doi: 10.1016/j.jaad.2012.11.004.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Biological Therapy / adverse effects
  • Dermatologic Agents / adverse effects*
  • Dermatologic Agents / therapeutic use
  • Female
  • Humans
  • Integrin alpha4
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Natalizumab
  • Pruritus / chemically induced
  • Skin Diseases / chemically induced*
  • Skin Diseases / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • Natalizumab
  • Integrin alpha4